Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.
Chan JA, Zhu AX, Stuart K, Bhargava P, Earle CC, Clark JW, Casey C, Regan E, Kulke MH.
Chan JA, et al. Among authors: kulke mh.
Cancer Chemother Pharmacol. 2010 Oct;66(5):961-8. doi: 10.1007/s00280-010-1248-6. Epub 2010 Feb 4.
Cancer Chemother Pharmacol. 2010.
PMID: 20130879
Free PMC article.
Clinical Trial.